Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin

por Zhao, Yang, He, MinKe, Liang, RunBin, Li, QiJiong, Shi, Ming
Publicado 2021

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity

por Li, Qijiong, Liu, Xiaofeng, Jin, Kemin, Lu, Min, Zhang, Chunfeng, Du, Xiaojuan, Xing, Baocai
Publicado 2017

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature

por Huang, Jun, Li, Qijiong, Zheng, Yun, Shen, Jingxian, Li, Binkui, Zou, Ruhai, Wang, Jianping, Yuan, Yunfei
Publicado 2014

One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

por Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming
Publicado 2022

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

por He, Wei, Zeng, Qingli, Zheng, Yun, Chen, Meixian, Shen, Jingxian, Qiu, Jiliang, Chen, Miao, Zou, Ruhai, Liao, Yadi, Li, Qijiong, Wu, Xianqiu, Li, Binkui, Yuan, Yunfei
Publicado 2015

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

por He, MinKe, Li, Qing, Shen, JingXian, Tan, GuoSheng, Li, QiJiong, Lai, JiaYing, Wei, Wei, Zhang, YaoJun, Zou, RuHai, Chen, MinShan, Guo, RongPing, Shi, Ming
Publicado 2019

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Su...

por Huang, YeXing, Zhang, LiHong, He, MinKe, Lai, ZhiCheng, Bu, XiaoYun, Wen, DongSheng, Li, QiJiong, Xu, Li, Wei, Wei, Zhang, YaoJun, Zhou, ZhongGuo, Chen, MinShan, Guo, RongPing, Shi, Ming, Kan, Anna
Publicado 2022